Global Biologics and Biosimilars Competitive Landscape Professional Research Report 2025
Description
Global Biologics and Biosimilars Competitive Landscape Professional Research Report 2025
Research Summary
Biologics are pharmaceutical drugs derived from living organisms, such as proteins, antibodies, or nucleic acids. They are produced using biotechnology processes and are used for the treatment of various diseases, including cancer, autoimmune disorders, and genetic diseases. Biologics are often highly complex and require specialized manufacturing techniques to ensure their safety, efficacy, and consistency. Biosimilars, on the other hand, are biological products that are highly similar to an already approved reference biologic. They are developed to have comparable efficacy, safety, and quality to the reference product and undergo rigorous testing to demonstrate similarity. Biosimilars offer a more affordable alternative to the original biologic, providing increased access to life-saving therapies. They are regulated by health authorities to ensure their quality, efficacy, and safety. Biologics and biosimilars have revolutionized the field of medicine, offering innovative and effective treatment options for patients with various medical conditions.
According to DIResearch's in-depth investigation and research, the global Biologics and Biosimilars market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Biologics and Biosimilars include Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, Biogen, Celltrion, Sobi, 3SBIO, Changchun High Tech, Kanghong Pharma, Innovent Biologics, Gan&Lee, Tonghua Dongbao, United Laboratory etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Biologics and Biosimilars. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Biologics and Biosimilars market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Biologics and Biosimilars market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Biologics and Biosimilars industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Biologics and Biosimilars Include:
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Biogen
Celltrion
Sobi
3SBIO
Changchun High Tech
Kanghong Pharma
Innovent Biologics
Gan&Lee
Tonghua Dongbao
United Laboratory
Biologics and Biosimilars Product Segment Include:
Monoclonal Antibodies
Interferon
Insulin
Vaccines
Others
Biologics and Biosimilars Product Application Include:
Hospital
Retail Pharmacy
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Biologics and Biosimilars Industry PESTEL Analysis
Chapter 3: Global Biologics and Biosimilars Industry Porter’s Five Forces Analysis
Chapter 4: Global Biologics and Biosimilars Major Regional Market Size and Forecast Analysis
Chapter 5: Global Biologics and Biosimilars Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Biologics and Biosimilars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Biologics and Biosimilars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Biologics and Biosimilars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Biologics and Biosimilars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Biologics and Biosimilars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Biologics and Biosimilars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Biologics and Biosimilars Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Biologics and Biosimilars Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Biologics and Biosimilars Product by Type
- 1.2.1 Monoclonal Antibodies
- 1.2.2 Interferon
- 1.2.3 Insulin
- 1.2.4 Vaccines
- 1.2.5 Others
- 1.3 Biologics and Biosimilars Product by Application
- 1.3.1 Hospital
- 1.3.2 Retail Pharmacy
- 1.3.3 Other
- 1.4 Global Biologics and Biosimilars Market Size Analysis (2020-2032)
- 1.5 Biologics and Biosimilars Market Development Status and Trends
- 1.5.1 Biologics and Biosimilars Industry Development Status Analysis
- 1.5.2 Biologics and Biosimilars Industry Development Trends Analysis
- 2 Biologics and Biosimilars Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Biologics and Biosimilars Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Biologics and Biosimilars Market Analysis by Regions
- 4.1 Biologics and Biosimilars Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Biologics and Biosimilars Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Biologics and Biosimilars Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Biologics and Biosimilars Revenue Forecast by Region (2026-2032)
- 5 Global Biologics and Biosimilars Market Size by Type and Application
- 5.1 Global Biologics and Biosimilars Market Size by Type (2020-2032)
- 5.2 Global Biologics and Biosimilars Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Biologics and Biosimilars Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Biologics and Biosimilars Market Size by Type
- 6.4 North America Biologics and Biosimilars Market Size by Application
- 6.5 North America Biologics and Biosimilars Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Biologics and Biosimilars Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Biologics and Biosimilars Market Size by Type
- 7.4 Europe Biologics and Biosimilars Market Size by Application
- 7.5 Europe Biologics and Biosimilars Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Biologics and Biosimilars Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Biologics and Biosimilars Market Size by Type
- 8.4 China Biologics and Biosimilars Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Biologics and Biosimilars Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Biologics and Biosimilars Market Size by Type
- 9.4 APAC (excl. China) Biologics and Biosimilars Market Size by Application
- 9.5 APAC (excl. China) Biologics and Biosimilars Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Biologics and Biosimilars Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Biologics and Biosimilars Market Size by Type
- 10.4 Latin America Biologics and Biosimilars Market Size by Application
- 10.5 Latin America Biologics and Biosimilars Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Biologics and Biosimilars Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Biologics and Biosimilars Market Size by Type
- 11.4 Middle East & Africa Biologics and Biosimilars Market Size by Application
- 11.5 Middle East & Africa Biologics and Biosimilars Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Biologics and Biosimilars Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Biologics and Biosimilars Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Biologics and Biosimilars Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Roche
- 13.1.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Roche Biologics and Biosimilars Product Portfolio
- 13.1.3 Roche Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Amgen
- 13.2.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Amgen Biologics and Biosimilars Product Portfolio
- 13.2.3 Amgen Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 AbbVie
- 13.3.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 AbbVie Biologics and Biosimilars Product Portfolio
- 13.3.3 AbbVie Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Sanofi
- 13.4.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Sanofi Biologics and Biosimilars Product Portfolio
- 13.4.3 Sanofi Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Johnson & Johnson
- 13.5.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Johnson & Johnson Biologics and Biosimilars Product Portfolio
- 13.5.3 Johnson & Johnson Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Pfizer
- 13.6.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Pfizer Biologics and Biosimilars Product Portfolio
- 13.6.3 Pfizer Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Novo Nordisk
- 13.7.1 Novo Nordisk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Novo Nordisk Biologics and Biosimilars Product Portfolio
- 13.7.3 Novo Nordisk Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Eli Lilly
- 13.8.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Eli Lilly Biologics and Biosimilars Product Portfolio
- 13.8.3 Eli Lilly Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Novartis
- 13.9.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Novartis Biologics and Biosimilars Product Portfolio
- 13.9.3 Novartis Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Merck
- 13.10.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Merck Biologics and Biosimilars Product Portfolio
- 13.10.3 Merck Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Biogen
- 13.11.1 Biogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Biogen Biologics and Biosimilars Product Portfolio
- 13.11.3 Biogen Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Celltrion
- 13.12.1 Celltrion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Celltrion Biologics and Biosimilars Product Portfolio
- 13.12.3 Celltrion Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 Sobi
- 13.13.1 Sobi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Sobi Biologics and Biosimilars Product Portfolio
- 13.13.3 Sobi Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 3SBIO
- 13.14.1 3SBIO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 3SBIO Biologics and Biosimilars Product Portfolio
- 13.14.3 3SBIO Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.15 Changchun High Tech
- 13.15.1 Changchun High Tech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Changchun High Tech Biologics and Biosimilars Product Portfolio
- 13.15.3 Changchun High Tech Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.16 Kanghong Pharma
- 13.16.1 Kanghong Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 Kanghong Pharma Biologics and Biosimilars Product Portfolio
- 13.16.3 Kanghong Pharma Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.17 Innovent Biologics
- 13.17.1 Innovent Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.17.2 Innovent Biologics Biologics and Biosimilars Product Portfolio
- 13.17.3 Innovent Biologics Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.18 Gan&Lee
- 13.18.1 Gan&Lee Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.18.2 Gan&Lee Biologics and Biosimilars Product Portfolio
- 13.18.3 Gan&Lee Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.19 Tonghua Dongbao
- 13.19.1 Tonghua Dongbao Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.19.2 Tonghua Dongbao Biologics and Biosimilars Product Portfolio
- 13.19.3 Tonghua Dongbao Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.20 United Laboratory
- 13.20.1 United Laboratory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.20.2 United Laboratory Biologics and Biosimilars Product Portfolio
- 13.20.3 United Laboratory Biologics and Biosimilars Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Biologics and Biosimilars Industry Chain Analysis
- 14.2 Biologics and Biosimilars Industry Raw Material and Suppliers Analysis
- 14.2.1 Biologics and Biosimilars Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Biologics and Biosimilars Typical Downstream Customers
- 14.4 Biologics and Biosimilars Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
